Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

ClinicalTrials.gov ID: NCT06516952

Public ClinicalTrials.gov record NCT06516952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Study identification

NCT ID
NCT06516952
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
349 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2024 (Actual)
Primary completion
Oct 19, 2026 (Estimated)
Completion
May 3, 2027 (Estimated)
Last update posted
May 28, 2026

2024 – 2027

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Cahaba Dermatology Birmingham Alabama 35244 —
Banner - University Medicine Multispecialty Services Clinic Tucson Arizona 85718 —
Premier Dermatology Clinical Trials Institute At Northwest Arkansas Fayetteville Arkansas 72703 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Dermatology Research Associates Los Angeles California 90045 —
Northridge Northridge California 91325 —
Rendon Center the Dermatology and Aesthetic Center Boca Raton Florida 33486 —
Driven Research Llc Coral Gables Florida 33134 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Research Institute of the Southeast, Llc West Palm Beach Florida 33401 —
Illinois Dermatology Institute the Chicago Loop Chicago Illinois 60602 —
Chicago Cosmetic Surgery and Dermatology Chicago Illinois 60654 —
Center For Medical Dermatology and Immunology Research Chicago Illinois 60657 —
Northshore University Healthsystem Skokie Illinois 60077 —
Dermatology Specialists Research Indiana Clarksville Indiana 47129 —
Oakland Hills Dermatology Auburn Hills Michigan 48326 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Somerset Skin Centre Troy Michigan 48084 —
Medisearch Clinical Trials Saint Joseph Missouri 64506 —
Washington University School of Medicine St Louis Missouri 63110 —
The University of New Mexico Unm Health Sciences Center Hsc Albuquerque New Mexico 87131 —
Montefiore Medical Center East Syracuse New York 13057 —
Skin Center Dermatology Group New York New York 10956 —
Stony Brook Dermatology Associates Stony Brook New York 11790 —
Centricity Research Columbus Columbus Ohio 43213 —
Wright State Physicians Health Center Dayton Ohio 45324 —
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130 —
Dermatology Treatment and Research Center Dallas Texas 75230 —
Sweetwater Dermatology Sugar Land Texas 77479 —
Center For Clinical Studies Webster Texas 77598 —
Frontier Dermatology Mill Creek Washington 98012 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06516952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06516952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →